Eli Lillys diabetes drug Mounjaro (tirzepatide), meanwhile, pulled in over $5 billion for the company last year, and its recently approved obesity drug Zepbound (also tirzepatide) is expected to increase revenues in the future
GLP-1 for Fitness Enthusiasts Who Train Hard Fitness enthusiasts often assume they dont qualify for medical weight loss
This means you could avoid long wait times or multiple clinic visits
These medications: Increase satiety Reduce appetite Slow digestion However, these treatments require injections, medical supervision, and ongoing use
As demand for these medications has grown, many plans are using utilization management strategies, including: Prior authorization Step therapy Formulary exclusions Higher BMI eligibility thresholds Requirements for multiple obesity-related comorbidities Mandatory lifestyle programs At the same time, access is becoming more complex